{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:45:03Z","timestamp":1794919503958,"version":"4.9.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016275","name":"Seoul National University Bundang Hospital","doi-asserted-by":"publisher","award":["02-2021-0050"],"award-info":[{"award-number":["02-2021-0050"]}],"id":[{"id":"10.13039\/100016275","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["European J Hybrid Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Autonomously functioning thyroid nodules (AFTNs) are treated with iodine-131 (I-131) therapy, which increases the risk of permanent hypothyroidism; however, the risk can be reduced by separately estimating the accumulated activity for the AFTN and extranodular thyroid tissue (ETT).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A quantitative I-123 single-photon emission computed tomography (SPECT)\/CT (5\u00a0mCi) was performed in one patient with unilateral AFTN and T3 thyrotoxicosis. The I-123 concentrations measured at 24\u00a0h were 12.26\u00a0\u00b5Ci\/mL and 0.11\u00a0\u00b5Ci\/mL in the AFTN and contralateral ETT, respectively. Thus, the I-131 concentrations and radioactive iodine uptake expected at 24\u00a0h by 5\u00a0mCi of I-131 were 38.59\u00a0\u00b5Ci\/mL and 0.31 for the AFTN and 0.34\u00a0\u00b5Ci\/mL and 0.007 for the contralateral ETT. The weight was calculated as CT-measured volume multiplied by 1.03.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the AFTN patient with thyrotoxicosis, we administered 30\u00a0mCi of I-131, which would maximize the 24-h I-131 concentration in the AFTN (226.86\u00a0\u00b5Ci\/g) and maintain a tolerable concentration in the ETT (1.97\u00a0\u00b5Ci\/g). The percentage of I-131 uptake at 48\u00a0h post I-131 administration was 62.6%. The patient achieved a euthyroid state at 14\u00a0weeks and maintained the state until 2\u00a0years post I-131 administration with an AFTN volume reduction of 61.38%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The pre-therapeutic planning of quantitative I-123 SPECT\/CT may enable a therapeutic window for I-131 therapy, which directs optimal I-131 activity to effectively treat AFTN while preserving the normal thyroid tissue.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41824-022-00159-w","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:03:17Z","timestamp":1676851397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Quantitative Iodine-123 single-photon emission computed tomography\/computed tomography for Iodine-131 therapy of an autonomously functioning thyroid nodule"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9188-6921","authenticated-orcid":false,"given":"Won Woo","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo Sung","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"key":"159_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2796.1991.tb00371.x","volume":"229","author":"J Berglund","year":"1991","unstructured":"Berglund J, Christensen SB, Dymling JF, Hallengren B (1991) The incidence of recurrence and hypothyroidism following treatment with antithyroid drugs, surgery or radioiodine in all patients with thyrotoxicosis in Malmo during the period 1970\u20131974. J Intern Med 229:435\u2013442. https:\/\/doi.org\/10.1111\/j.1365-2796.1991.tb00371.x","journal-title":"J Intern Med"},{"key":"159_CR2","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s00259-010-1488-z","volume":"37","author":"M Bocher","year":"2010","unstructured":"Bocher M, Blevis IM, Tsukerman L, Shrem Y, Kovalski G, Volokh L (2010) A fast cardiac gamma camera with dynamic SPECT capabilities: design, system validation and future potential. Eur J Nucl Med Mol Imaging 37:1887\u20131902. https:\/\/doi.org\/10.1007\/s00259-010-1488-z","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"159_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1365-2265.2005.02218.x","volume":"62","author":"C Ceccarelli","year":"2005","unstructured":"Ceccarelli C, Bencivelli W, Vitti P, Grasso L, Pinchera A (2005) Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years\u2019 retrospective study. Clin Endocrinol (oxf) 62:331\u2013335. https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02218.x","journal-title":"Clin Endocrinol (oxf)"},{"key":"159_CR4","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2967\/jnumed.108.060020","volume":"50","author":"SS Gambhir","year":"2009","unstructured":"Gambhir SS, Berman DS, Ziffer J, Nagler M, Sandler M, Patton J et al (2009) A novel high-sensitivity rapid-acquisition single-photon cardiac imaging camera. J Nucl Med 50:635\u2013643. https:\/\/doi.org\/10.2967\/jnumed.108.060020","journal-title":"J Nucl Med"},{"key":"159_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1089\/thy.2015.0396","volume":"26","author":"A Gandhi","year":"2016","unstructured":"Gandhi A, Wong KK, Gross MD, Avram AM (2016) Lingual thyroid ectopia: diagnostic SPECT\/CT imaging and radioactive iodine treatment. Thyroid 26:573\u2013579. https:\/\/doi.org\/10.1089\/thy.2015.0396","journal-title":"Thyroid"},{"key":"159_CR6","first-page":"888","volume":"26","author":"JI Hamburger","year":"1985","unstructured":"Hamburger JI, Hamburger SW (1985) Diagnosis and management of large toxic multinodular goiters. J Nucl Med 26:888\u2013892","journal-title":"J Nucl Med"},{"key":"159_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1210\/er.2002-0016","volume":"24","author":"L Hegedus","year":"2003","unstructured":"Hegedus L, Bonnema SJ, Bennedbaek FN (2003) Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24:102\u2013132. https:\/\/doi.org\/10.1210\/er.2002-0016","journal-title":"Endocr Rev"},{"key":"159_CR8","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1056\/NEJM199805143382007","volume":"338","author":"AR Hermus","year":"1998","unstructured":"Hermus AR, Huysmans DA (1998) Treatment of benign nodular thyroid disease. N Engl J Med 338:1438\u20131447. https:\/\/doi.org\/10.1056\/NEJM199805143382007","journal-title":"N Engl J Med"},{"key":"159_CR9","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1210\/jc.2014-1347","volume":"99","author":"T Krohn","year":"2014","unstructured":"Krohn T, Hanscheid H, Muller B, Behrendt FF, Heinzel A, Mottaghy FM et al (2014) Maximum dose rate is a determinant of hypothyroidism after 131I therapy of Graves\u2019 disease but the total thyroid absorbed dose is not. J Clin Endocrinol Metab 99:4109\u20134115. https:\/\/doi.org\/10.1210\/jc.2014-1347","journal-title":"J Clin Endocrinol Metab"},{"key":"159_CR10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s13139-019-00588-9","volume":"53","author":"WW Lee","year":"2019","unstructured":"Lee WW, Group KS (2019) Clinical applications of technetium-99m quantitative single-photon emission computed tomography\/computed tomography. Nucl Med Mol Imaging 53:172\u2013181. https:\/\/doi.org\/10.1007\/s13139-019-00588-9","journal-title":"Nucl Med Mol Imaging"},{"key":"159_CR11","doi-asserted-by":"publisher","first-page":"e4170","DOI":"10.1097\/MD.0000000000004170","volume":"95","author":"H Lee","year":"2016","unstructured":"Lee H, Kim JH, Kang YK, Moon JH, So Y, Lee WW (2016) Quantitative single-photon emission computed tomography\/computed tomography for technetium pertechnetate thyroid uptake measurement. Medicine (baltimore) 95:e4170. https:\/\/doi.org\/10.1097\/MD.0000000000004170","journal-title":"Medicine (baltimore)"},{"key":"159_CR12","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.7863\/jum.2008.27.12.1727","volume":"27","author":"R Malago","year":"2008","unstructured":"Malago R, D\u2019Onofrio M, Ferdeghini M, Mantovani W, Colato C, Brazzarola P et al (2008) Thyroid volumetric quantification: comparative evaluation between conventional and volumetric ultrasonography. J Ultrasound Med 27:1727\u20131733. https:\/\/doi.org\/10.7863\/jum.2008.27.12.1727","journal-title":"J Ultrasound Med"},{"key":"159_CR13","first-page":"260","volume":"59","author":"LD Marinelli","year":"1948","unstructured":"Marinelli LD, Quimby EH, Hine GJ (1948) Dosage determination with radioactive isotopes; practical considerations in therapy and protection. Am J Roentgenol Radium Ther 59:260\u2013281","journal-title":"Am J Roentgenol Radium Ther"},{"key":"159_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/thy.1998.8.223","volume":"8","author":"B Nygaard","year":"1998","unstructured":"Nygaard B (1998) Changes in the thyroid technetium-99m scintigram after antithyroid and subsequent radioiodine treatment for solitary autonomous nodules. Thyroid 8:223\u2013227. https:\/\/doi.org\/10.1089\/thy.1998.8.223","journal-title":"Thyroid"},{"key":"159_CR15","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1136\/bmj.307.6908.828","volume":"307","author":"B Nygaard","year":"1993","unstructured":"Nygaard B, Hegedus L, Gervil M, Hjalgrim H, Soe-Jensen P, Hansen JM (1993) Radioiodine treatment of multinodular non-toxic goitre. BMJ 307:828\u2013832. https:\/\/doi.org\/10.1136\/bmj.307.6908.828","journal-title":"BMJ"},{"key":"159_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/j.1600-0455.2002.430307.x","volume":"43","author":"B Nygaard","year":"2002","unstructured":"Nygaard B, Nygaard T, Court-Payen M, Jensen LI, Soe-Jensen P, Gerhard Nielsen K et al (2002) Thyroid volume measured by ultrasonography and CT. Acta Radiol 43:269\u2013274. https:\/\/doi.org\/10.1080\/j.1600-0455.2002.430307.x","journal-title":"Acta Radiol"},{"key":"159_CR17","doi-asserted-by":"publisher","first-page":"488","DOI":"10.7326\/0003-4819-101-4-488","volume":"101","author":"DS Ross","year":"1984","unstructured":"Ross DS, Ridgway EC, Daniels GH (1984) Successful treatment of solitary toxic thyroid nodules with relatively low-dose iodine-131, with low prevalence of hypothyroidism. Ann Intern Med 101:488\u2013490. https:\/\/doi.org\/10.7326\/0003-4819-101-4-488","journal-title":"Ann Intern Med"},{"key":"159_CR18","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL et al (2016) 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26:1343\u20131421. https:\/\/doi.org\/10.1089\/thy.2016.0229","journal-title":"Thyroid"},{"key":"159_CR19","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.2967\/jnumed.112.105148","volume":"53","author":"EB Silberstein","year":"2012","unstructured":"Silberstein EB, Alavi A, Balon HR, Clarke SE, Divgi C, Gelfand MJ et al (2012) The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0. J Nucl Med 53:1633\u20131651. https:\/\/doi.org\/10.2967\/jnumed.112.105148","journal-title":"J Nucl Med"},{"key":"159_CR20","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1210\/jcem.86.3.7244","volume":"86","author":"MF Wesche","year":"2001","unstructured":"Wesche MF, Tiel VBMM, Lips P, Smits NJ, Wiersinga WM (2001) A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab 86:998\u20131005. https:\/\/doi.org\/10.1210\/jcem.86.3.7244","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Hybrid Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-022-00159-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41824-022-00159-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-022-00159-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:03:21Z","timestamp":1676851401000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhi.springeropen.com\/articles\/10.1186\/s41824-022-00159-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["159"],"URL":"https:\/\/doi.org\/10.1186\/s41824-022-00159-w","relation":{},"ISSN":["2510-3636"],"issn-type":[{"value":"2510-3636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]},"assertion":[{"value":"31 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board (IRB) approved the study design (Institution: Seoul National University Bundang Hospital).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The subject provided an informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"It was waved by the IRB.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}